Brief: Initiator Pharma Signs Option Agreement For Phase 2 Ready Drug Candidate

Initiator Pharma A/S

08/11/2018 07:23

Initiator Pharma A/S  INIT.TE :
    * INITIATOR PHARMA SIGNS OPTION AGREEMENT FOR PHASE 2 READY
DRUG
CANDIDATE
    * SIGNED AN OPTION AGREEMENT WITH SANIONA AB, FOR A PHASE 2
READY
DRUG CANDIDATE.
    * SANIONA MAY RECEIVE UP TO 20 PERCENT OF FUTURE PAYMENTS TO
INITIATOR PHARMA
    * AGREEMENT BETWEEN INITIATOR PHARMA AND SANIONA INVOLVES NO
UPFRONT AND MILESTONE PAYMENTS
    * INITIATOR PHARMA HAS SECURED A 1 YEAR EXCLUSIVE OPTION
AGREEMENT
FOR A PHASE 2 READY COMPOUND, AN788
    * AGREEMENT BETWEEN INITIATOR PHARMA AND SANIONA INVOLVES NO
UPFRONT AND MILESTONE PAYMENTS
    * SANIONA MAY RECEIVE UP TO 20 PERCENT OF FUTURE PAYMENTS TO
INITIATOR PHARMA IN RELATION TO AN788 AND SINGLE DIGIT ROYALTIES
ON PRODUCTS SALES

Source text for Eikon:  ID:nWkr1pnpz5 
Further company coverage:  INIT.TE